A carregar...
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
Atrial fibrillation (AF) is associated with significant morbidity and mortality related to stroke due to thromboembolism. Several novel oral anticoagulants (NOACs) have been developed that dose-dependently inhibit thrombin or activated factor X (factor Xa). These new agents offer potential advantage...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321074/ https://ncbi.nlm.nih.gov/pubmed/25713732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.01.23 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|